Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Serotypes of Chlamydia trachomatis and Risk for Development of Cervical Squamous Cell Carcinoma

Article Abstract:

Women who are infected with chlamydia have an increased risk of developing cervical cancer. In a study of 128 women with squamous cell cervical cancer and 384 healthy women, Chlamydia trachomatis serotype G was most strongly linked to cervical cancer.

Author: Pukkala, Eero, Dillner, Joakim, Anttila, Tarja, Saikku, Pekka, Koskela, Pentti, Bloigu, Aini, Ikaheimo, Irma, Jellum, Egil, Lehtinen, Matti, Lenner, Per, Hakulinen, Timo, Narvanen, Ale, Thoresen, Steinar, Youngman, Linda, Paavonen, Jorma
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Chlamydia infections

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck

Article Abstract:

Infection with human papillomavirus 16 appears to be a risk factor for squamous cell cancer of the head and neck. This was the conclusion of a study of 292 people with squamous cell head and neck cancer and 1,568 healthy volunteers. This virus has also been linked to cervical cancer.

Author: Pukkala, Eero, Dillner, Joakim, Koskela, Pentti, Jellum, Egil, Lehtinen, Matti, Youngman, Linda, Mork, Jon, Lie, A. Kathrine, Glattre, Eystein, Hallmans, Goran, Moller, Bjorn, Schiller, John T.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
Head and neck cancer

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later

Article Abstract:

A blood test based on the E6 and E7 proteins from human papillomavirus types 16 and 18 is not very accurate in identifying women infected with the virus who may develop cervical cancer, according to a study of 550,000 women. Only 7% of the women who eventually developed cervical cancer had antibodies to these viral proteins in blood samples taken up to 20 years earlier. Some types of human papillomavirus have been linked to cervical cancer, especially types 16 and 18.

Author: Pukkala, Eero, Dillner, Joakim, Koskela, Pentti, Jellum, Egil, Lehtinen, Matti, Thoresen, Steinar, Paavonen, Jorma, Hakama, Matti, Pawlita, Michael, Zumbach, Klaus, Lie, Katherine, Luostarinen, Tapio, Sigstad, Eva
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2003
HEALTH SERVICES, Medical and Diagnostic Laboratories, Blood Test Procedures, Evaluation, Diagnosis, Medical examination, Blood, Blood tests

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Risk factors, Cervical cancer, Squamous cell carcinoma, Papillomavirus infections
Similar abstracts:
  • Abstracts: The natural history of a positive response to transfundal pressure in women at risk for cervical incompetence
  • Abstracts: A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia
  • Abstracts: Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
  • Abstracts: Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies
  • Abstracts: Intravenous infusion of magnesium sulfate and regional redistribution of fetal blood flow during maternal hemorrhage in late-gestation gravid ewes
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.